1. insights
  2. strategy catalyst
  3. health policy and advocacy
  4. federal judge sides with hrsa on 340b but leaves door open for drugmaker
Strategist | strategy-catalyst

Federal judge sides with HRSA on 340B, but leaves door open for drugmaker rebates

Visual banner featuring the text "The Strategist" and a graphic evoking a football play diagram.
  • On May 15, a federal judge ruled that pharmaceutical companies can’t withhold upfront 340B discounts without federal approval, but also directed HRSA to reconsider Sanofi’s proposed rebate model.

If your organization is a member, you already have access.